Aller au contenu principal
Accès ouvert déclaré 2025 article

Nebulization Optimization for Management of Obstructive Airway Disorders: An Expert Review (NOVA-ER)

0Citations signalées, ce qui n’est pas une note de qualité
12Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : in, kw, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Nebulization therapy is an essential inhalation technique for managing obstructive airway diseases such as asthma, bronchiectasis, and chronic obstructive pulmonary disease (COPD). In Indian clinical settings, factors such as diverse patient populations, varying disease severity, and healthcare accessibility influence treatment decisions. While clinicians rely on the only available nebulization guideline, its vastness and complexity pose challenges in practical application. Navigating these guidelines and translating recommendations into routine practice remains difficult. Objective: The NOVA-ER manuscript aims to develop a structured, evidence-based, and expert-driven reference document to streamline nebulization practices in clinical settings and provide guidance for home nebulization. Methods: A comprehensive review of peer-reviewed literature, clinical guidelines, and systematic reviews was conducted using databases such as PubMed, MEDLINE, and the Cochrane Library, with a focus on studies published in the last ten years to ensure relevance. Additionally, expert opinions were gathered through a structured panel discussion involving specialists in respiratory medicine. A predefined set of questions guided these discussions, and clinical feedback was incorporated to refine recommendations. Key Takeaways: This manuscript presents stepwise algorithms tailored to individual obstructive airway diseases, facilitating decision-making for both rescue and maintenance therapy. It also helps identify suitable candidates and agents for home nebulization while providing disease-specific guidance for effective nebulization treatment. Furthermore, it integrates expert perspectives with current clinical evidence to optimize nebulization practices. Conclusion: NOVA-ER serves as a practical tool for clinicians, researchers, and policymakers, offering structured guidance to enhance nebulization practices, support home nebulization, and bridge the gap between evidence-based guidelines and its practical applicability in clinical care which may help improving patient outcomes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Nebulization Optimization for Management of Obstructive Airway Disorders: An Expert Review (NOVA-ER)
Date Crossref
01/01/2025
Éditeur
Knowledge Enterprise Journals
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Inhalation and Respiratory Drug Delivery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.